FROM INTRAVENOUS TO SUBCUTANEOUS INFLIXIMAB – A TRANSITION LEADING TO CHANGES?

Maria José Temido  1     Andrea Emília Pereira Silva  1     Mafalda João  2     Raquel Pimentel  2     Catarina Correia  2     Sandra Lopes  2     Sofia Mendes  2     Pedro Narra Figueiredo  2     Francisco Silva Portela  2    
1 Centro Hospitalar e Universitário de Coimbra, Coimbra, Portugal
2 Portuguese Oncology Institute of Coimbra, Coimbra, Portugal

Session
IBD (Posters)

Conference
UEG Week 2022

Citation
United European Gastroenterology Journal 2022; 10 (Supplement 8)


Login to access library content

Login

Do you need help setting up your myUEG account?
Contact us at [email protected]

New to myUEG?

Create myUEG account

Social Sharing